AARDEX Group

The fallacy of pill count: evidences of pill dumping in HIV infected adolescents in Zimbabwe

pill_dump_img
NOV-2017 : Frequently, poor-responders with high pill count adherence are dumping

NOV-2017 : Frequently, poor-responders with high pill count adherence are dumping their pills. This bias happens across the board… even in a low resource settings as HIV in Zimbabwe. Great work using the MEMS® back in 2015! Was it on your radar?

The fallacy of pill count: evidences of pill dumping in HIV infected adolescents in Zimbabwe

We walk the talk

In a 2015 study 44% of the HIV infected adolescents receiving a boosted protease inhibitor treatment had their viral load uncontrolled. When the adherence was measured using pill count the average adherence was 100% (range = 93–100%). Without the MEMS reliable and rich adherence measurement, the problem would have been seen as a lack of efficacy requiring therapeutic escalation. In fact, the adherence measured with MEMS showed the real issue, an average adherence level of 41% (range = 3–100%).

By moving the focus to adherence management, the real issues can be addressed. Measure, understand and manage…

  • Measure the real adherence in your population
  • Understand which patients are having which problems
  • Manage the barriers, even the ones that the patients were not aware of, set up goals and review the evaluation on the next visit.

MEMS®, we provide the tools

You make the difference

Reach out to us at MEMS@aardexgroup.com to receive more information about the use of the MEMS® (Medication Event Monitoring System).

Best Regards,

The MEMS® team

Share This Post

You may also like...

Outsourcing in Clinical Trials Europe (1)
Breaking News

Meet us at Outsourcing in Clinical Trials Europe 2023

Exciting news! AARDEX Group is gearing up for one of the most highly anticipated events in the clinical trials industry – the 13th Annual Outsourcing in Clinical Trials Europe conference, which will take place in the beautiful city of Barcelona